Vertex Pharmaceuticals Inc. announced a national reimbursement agreement with the French Health Authorities for the cystic fibrosis medicines KAFTRIO® in a combination regimen with ivacaftor and SYMKEVIsup>® in combination with ivacaftor.
[Vertex Pharmaceuticals, Inc.]
7753456
{7753456:nan}
apa
50
1
164046
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
